5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 15.02▼ | 15.05▼ | 15.06▼ | 14.82▲ | 14.94▲ |
MA10 | 15.04▼ | 14.99▲ | 14.93▲ | 14.66▲ | 14.77▲ |
MA20 | 14.88▲ | 14.76▲ | 14.68▲ | 14.97▲ | 14.32▲ |
MA50 | 14.66▲ | 14.60▲ | 14.67▲ | 14.71▲ | 13.29▲ |
MA100 | 14.64▲ | 14.85▲ | 15.01▼ | 14.22▲ | 12.87▲ |
MA200 | 14.95▲ | 14.97▲ | 14.80▲ | 13.43▲ | 12.94▲ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.001▲ | 0.030▲ | 0.055▲ | -0.009▼ | 0.000▼ |
RSI | 62.516▲ | 60.997▲ | 62.014▲ | 53.210▲ | 61.227▲ |
STOCH | 52.217 | 77.575 | 88.382▲ | 50.690 | 59.881 |
WILL %R | -35.135 | -23.214▲ | -16.667▲ | -41.221 | -38.559 |
CCI | 18.412 | 50.967 | 63.465 | 17.588 | 48.546 |
Friday, April 26, 2024 12:26 AM
If you suffered losses exceeding $100,000 investing in Blue stock or options between April 24, 2023 and December 8, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh ...
|
Wednesday, April 24, 2024 09:40 AM
Despite recent FDA approvals for gene editing technology, CRISPR Therapeutics' stock declined. Click here to read an analysis of CRSP stock now.
|
Tuesday, April 23, 2024 09:00 AM
Albemarle Corp. engages in the development, manufacture, and marketing of chemicals for consumer electronics, petroleum refining, utilities, packaging, construction, transportation ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
25/04/24 | 14.96 | 15.08 | 14.68 | 14.99 | 25,200 |
24/04/24 | 15.11 | 15.15 | 14.98 | 15.02 | 41,400 |
23/04/24 | 14.42 | 15.14 | 14.42 | 15.08 | 51,700 |
22/04/24 | 14.39 | 14.70 | 14.39 | 14.69 | 36,900 |
19/04/24 | 14.42 | 14.79 | 14.34 | 14.34 | 36,800 |
18/04/24 | 14.93 | 14.93 | 14.22 | 14.42 | 76,400 |
17/04/24 | 14.40 | 15.11 | 14.40 | 14.80 | 62,600 |
16/04/24 | 14.33 | 14.47 | 14.26 | 14.37 | 39,000 |
15/04/24 | 14.62 | 14.90 | 14.31 | 14.33 | 48,700 |
12/04/24 | 15.00 | 15.26 | 14.54 | 14.59 | 43,400 |
|
|
||||
|
|
||||
|
|